Frequently Asked Questions
The market is segmented based on Global Point-of-Care Hba1c Testing Market Segmentation, By Product (Instruments and Consumables), Technology (ION– Exchange HPCL, Enzymatic Assay, Affinity Binding Chromatography, and Turbidimatric Inhibition Immunoassay), End-Users (Hospitals, Clinics, Ambulatory Surgery Centres, and Others) – Industry Trends and Forecast to 2032
.
The Global Point Of Care Hba1c Testing Market size was valued at USD 670.17 USD Million in 2024.
The Global Point Of Care Hba1c Testing Market is projected to grow at a CAGR of 5.59% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
